University at Buffalo neuroscientists have identified the binding site of low-dose ketamine, providing critical insight into ...

Depression and anxiety rank among the top global health challenges. Since 1990, these disorders have surged, placing them in ...

FDA supports CaaMTech's CT-4201 psilocin program for depression, advancing psychedelic therapy and clearing key regulatory ...

Learn more about how an anesthetic traditionally used for surgical procedures may help depression and what to expect during ...

Computer-assisted cognitive-behavior therapy (CCBT) and mobile mental health applications warrant continued development and ...

Repetitive transcranial magnetic stimulation offers rapid depression relief for patients unresponsive to conventional ...

Bright light therapy, a standard treatment for seasonal depression, may also help people who experience depression year-round ...

Depression disrupts the body's stress systems, causing physical health risks like heart disease, diabetes, and stroke, and reducing life expectancy by 7-10 years.

The first depression health economic modelling study, led by Professor Shirley Li Xue, from the LKS Faculty of Medicine, the ...

Now a sub-study at Uppsala University shows that there is also a risk that these patients will become depressed by the treatment. We found that beta blockers led to slightly higher levels of ...

Emerging research suggests that chronic inflammation, rather than neurotransmitter deficiencies alone, may be a major factor ...